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Visceral leishmaniasis (VL) is a life-threatening protozoal infection chiefly impinging
the rural and poor population in the tropical and sub-tropical countries. The deadly
affliction is rapidly expanding after its association with AIDS, swiftly defying its status
of a neglected disease. Despite successful formulation of vaccine against canine
leishmaniasis, no licensed vaccine is yet available for human VL, chemotherapy is
in appalling state, and the development of new candidate drugs has been painfully
slow. In face of lack of proper incentives, immunostimulatory plant preparations owing
antileishmanial efficacy bear potential to rejuvenate awful antileishmanial chemotherapy.
We have earlier reported profound leishmanicidal activity of Piper nigrum hexane (PNH)
seeds and P. nigrum ethanolic (PNE) fractions derived from P. nigrum seeds against
Leishmania donovani promastigotes and amastigotes. In the present study, we illustrate
that the remarkable anti-promastigote activity exhibited by PNH and PNE is mediated
via apoptosis as evidenced by phosphatidylserine externalization, DNA fragmentation,
arrest in sub G0/G1 phase, loss of mitochondrial membrane potential and generation
of reactive oxygen species. Further, P. nigrum bioactive fractions rendered significant
protection to L. donovani infected BALB/c mice in comparison to piperine, a known
compound present in Piper species. The substantial therapeutic potential of PNH and
PNE was accompanied by elicitation of cell-mediated immune response. The bioactive
fractions elevated the secretion of Th1 (INF-γ, TNF-α, and IL-2) cytokines and declined
IL-4 and IL-10. PNH and PNE enhanced the production of IgG2a, upregulated the
expression of co-stimulatory molecules CD80 and CD86, augmented splenic CD4+
and CD8+ T cell population, induced strong lymphoproliferative and DTH responses
and partially stimulated NO production. PNH and PNE were devoid of any hepatic or
renal toxicity. These encouraging findings merit further exploration of P. nigrum bioactive
fractions as a source of potent and non-toxic antileishmanials.
Keywords: Visceral leishmaniasis, antileishmanial, Piper nigrum, immunomodulatory, leishmanicidal, Leishmania
donovani, apoptosis
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INTRODUCTION
Leishmaniasis comprises poverty associated neglected vector-
borne diseases that are responsible for considerable morbidity
andmortality all over the world. Visceral manifestation is the life-
threatening form of the disease (Rogers, 2012) and is responsible
for 60,000 deaths annually, causing a death toll preceded only by
malaria in case of parasitic infections (Kaye and Aebischer, 2011).
VL is endemic in India apart from Bangladesh, Nepal, South
Sudan, Sudan, and Brazil which together account for 90% of the
200,000 to 400,000 new cases reported yearly (Chowdhury et al.,
2014). Clinically cured patients often suﬀer from relapse in the
form of post kala-azar dermal leishmaniasis and VL now poses a
serious threat as common co-infection with AIDS in endemic as
well as non-endemic countries (Cota et al., 2011).
The options available for VL control are limited due to non-
availability of any licensed vaccine, debilitating chemotherapy
which is riddled with emerging resistance, cost and toxicity,
and already failing combination therapy (Garcia-Hernandez
et al., 2012). Pentavalent antimonials constitute ﬁrst line of
drugs since their discovery more than 60 years ago; however,
their use has already been abandoned in Bihar, India, due
to resurgence of resistance. AmB, constitutes second line of
drugs and also serves as the ﬁrst choice of treatment in cases
where patients become unresponsive to antimonials. However,
its use is demerited by need of hospitalization, continuous
monitoring of patients, prolonged duration of treatment and
infusion-related side-eﬀects (fever, chills, thrombophlebitis).
More toxic but less common side-eﬀects include hypokalaemia,
nephrotoxicity, myocarditis, and even death. All these adverse
toxicities coupled with high cost, limit the choice of AmB as
a favorable treatment for leishmaniasis despite its tremendous
eﬃcacy. Lipid formulations of AmB although non-toxic, are
expensive which is a crucial drawback as leishmaniasis-inﬂicted
major population is chieﬂy rural and extremely poor. Newer
drugs such as miltefosine (oral agent) and paromomycin
have been registered for use in India against VL. However,
miltefosine is teratogenic, causes irreversible gastro-intestinal
Abbreviations: AIDS, acquired immunodeﬁciency syndrome; ALP, alkaline
phosphatase; AmB, Amphotericin B; ANOVA, one-way analysis of variance;
APC, allophycocyanin; BSA, bovine serum albumin; CFSE, carboxyﬂuorescein
succinimidyl ester; CL, cutaneous leishmaniasis; CMI, cell-mediated immunity;
ConA, Concanavalin A; CPCSEA, Committee for the purpose of control and
supervision of experiments on animals; DMSO, dimethylsulfoxide; DTH,
delayed type hypersensitivity; FBS, fetal bovine serum; FITC, ﬂuorescein
isothiocyanate; FT, freeze thawed antigen; GC-MS, Gas chromatography-Mass
spectrometry; HEPES, 4-(2-hydroxyethyl)-1-piperazine-ethanesulfonic acid;
H2DCFDA, 2′, 7′- dichlorodihydroﬂuorescein-diacetate; IgG, Immunoglubulin
G; i.p., intraperitoneal; i.v., intravenous; INF, infection control; JC-1,
5,5′,6,6′-tetrachloro-1,1′ ,3,3′-tetraethylimidacarbocyanine iodide; JHAEC, Jam
ia Hamdard Animal Ethics Committee; LDU, leishman donovan units; MFI;
mean ﬂuorescence intensity; MMP/m, mitochondrial membrane potential;
NO, nitirc oxide; NOSII; nitric oxide synthase II; PBS, phosphate buﬀered saline;
PE, Phycoerythrin; PI, propidium iodide; PIP; piperine; PNE, P. nigrum seeds
ethanolic fraction; PNH, P. nigrum seeds hexane fraction; PS, phosphatidylserine;
RBCs, red blood cells; ROS, reactive oxygen species; RPMI, Roswell Park
Memorial Institute; RT, room temperature; SEM, standard error of mean; SGOT,
serum glutamate oxaloacetate transaminase; SGPT, serum glutamate pyruvate
transaminase; SLA, soluble leishmanial antigen; Th, T helper type; TUNEL,
terminal deoxynucleotidyltransferase (TdT) mediated dUTP (deoxyuridine
triphosphate) nick end labeling; VC, vehicle control; VL, visceral leishmaniasis.
disturbances and renal toxicity, and there are reports of drug
resistance, which limits its usefulness (Sundar et al., 2006). On
the other hand, parenteral route of administration and other
baneful manifestations such as ototoxicity and nephrotoxicity
caused by paromomycin negatively impacts its use (Sundar
and Agarwal, 2011). Allopurinol is a purine analog and its
antileishmanial activity was discovered about three decades ago.
After Miltefosine, it was considered as another promising oral
agent and was investigated in clinical trials for CL and VL but
the results were not up to expectations. Despite this, it exhibited
good eﬃcacy against canine leishmaniasis and is employed in
maintenance therapy for canine leishmaniasis (Monzote, 2009).
Sitmaquine (8-aminoquinoline) once considered as a future oral
antileishmanial drug in pipeline, is no longer in development.
Sitamaquine was being developed by GlaxoSmithKline and
underwent extensive phase II trials in India and East Africa
where it exhibited <90% cure rates (Croft and Olliaro, 2011 and
references therein).
In order to ﬁnd cost-eﬀective and eﬃcacious alternatives,
the search for new drugs is directed toward exploration of
alternative sources. Plant kingdom has invariably served as an
inexhaustible source for drug discovery with boundless structural
and molecular diversity which has favoured the quest for more
eﬃcacious and safe therapeutics, against both parasitic and non-
parasitic diseases. Use of plant extracts in addition to plant
secondary metabolites for containment of antiparasitic diseases
including leishmaniasis is often recommended (Wink, 2012) and
it is claimed that crude or semipuriﬁed preparations of whole
plant or plant parts may be more eﬀective therapeutically (Kayser
et al., 2003). World Health Organization has also promoted the
use of plant extracts for oral and topical application in case of
VL and CL, respectively (Fournet and Munoz, 2002). Search
for plants derived antileishmanial drugs has been intensive and
innumerable plants belonging to diverse families have exhibited
appreciable leishmanicidal eﬃcacy (de Carvalho and Ferreira,
2001; Sen and Chatterjee, 2011; Brito et al., 2013).
Further, as the Leishmania parasites incapacitate the host
macrophages and impair their functioning, eventually leading
to suppression of CMI (Schmid et al., 2012), an ideal
approach to cure leishmaniasis should include administration of
antileishmanial compounds, which can concomitantly rejuvenate
the defective host immunity. Over the years, compounds with
dual antiparasitic and immunomodulatory potential have gained
prominence in the search for new and better leishmanicidal
agents. Several plant extracts and secondary metabolites have
resulted in therapeutic polarization of host immunity to treat
leishmaniasis (Chouhan et al., 2014a and references therein).
Thus, use of immunostimulatory plant extracts or compounds
alone or in combination with existing chemotherapy can lend
leishmaniasis therapy a new direction. As immunostimulatory
plant fractions are composed of multiple compounds they may
impact upon diverse molecular targets to eliminate the parasites
thereby reducing the risk of drug resistance (Spelman et al., 2006
and references therein).
Plants of Piperaceae family used as sources of ingredients
for food spices have been employed in traditional medicines
since ancient times. Plant extracts from various species
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of genus Piper have demonstrated potent leishmanicidal
eﬃcacy (Chouhan et al., 2014b and references therein).
Piper nigrum is a well-known medicinal plant exhibiting a
diverse range of biological activities that have been explored
in traditional medicinal systems of both new world and
old world countries (Srinivasan, 2007). Immunomodulatory
potential of P. nigrum has been well documented along with
its antiprotozoal properties (Shaba et al., 2012). We have
previously reported that seeds of P. nigrum bear profound
antileishmanial activity in vitro and ex vivo (Chouhan et al.,
2014b). P. nigrum hexane (PNH) and P. nigrum ethanolic (PNE)
fractions of seeds inhibited the growth of Leishmania donovani
promastigotes and amastigotes substantially in comparison
to piperine (PIP), one of the bioactive compounds present
in plants of Piper species. The plant secondary metabolites
present in these fractions were also identiﬁed by GC-MS.
In the present study, we extended our work to identify the
mode of induced cell death by these fractions in L. donovani
promastigotes as well as their protective eﬃcacy in vivo




All the chemicals used throughout the study were
procured from well-known standard companies. Sodium
dihydrogen phosphate, disodium hydrogen phosphate,
hydrogen peroxide, citric acid, o-phenylenediamine
dihydrochloride, ethanol, hexane, methanol, BSA, Folin’s
reagent, ammonium chloride, Trypan blue, sodium nitrite,
phosphoric acid, sulphanilamide, N-(1-napthyl) ethylene
dihyrochloride, and Tween-20 were procured from Merck.
FBS was purchased from GIBCO-BRL. All other chemicals
were purchased from Sigma-Aldrich unless otherwise
stated.
Methods
L. donovani Culture Maintenance
Leishmania donovani culture (MHOM/IN/83/AG83) was a
kind gift from Dr. Nahid Ali, Indian Institute of Chemical
Biology, Kolkata, West Bengal, India. L. donovani infection
was maintained in vivo in BALB/c mice. L. donovani parasites
were cultured in medium M199 plus 10% heat-inactivated
FBS as described previously (Chouhan et al., 2015). Brieﬂy,
promastigotes were subcultured at regular intervals (72–96 h)
after adjusting the inoculum density to 2 × 106 cells ml−1
at 22◦C.
Maintenance of Animals
BALB/c mice were reared in Central Animal House of Jamia
Hamdard, and females, aged 6–8 weeks and weighing about
20–25 g were used for carrying out in vivo experiments. The study
protocol was approved (Ethical approval judgment number, 499)
from the JHAEC which is registered under the CPCSEA.
Plant Material and Extraction
Piper nigrum dried fruits were purchased locally, and
authenticated by Dr. H.B. Singh, Taxonomist, NISCAIR,
CSIR, New Delhi (voucher no. NISCAIR/RHMD/Consult/-
2010-11/1440/38). The powdered plant material (100 g) was
subjected to sequential extraction with hexane, ethanol and water
as reported earlier (Chouhan et al., 2014b). The dried fractions
were stored at –20◦C until used for bioassay.
Determination of PS Externalization
Phosphatidylserine externalization was detected by Annexin–V
FLUOS staining kit (Roche). The stationary phase promastigotes
(2 × 106 cells ml−1) were either untreated or treated with PNH,
PNE, PIP, and pentamidine (500 μg ml−1) for 72 h at 22◦C.
The downstream processing was carried out according to the
manufacturer’s instructions. The parasites were incubated with
Annexin-V-FLOUS and PI (2 μl each) along with sample buﬀer
(100 μl) for 15 min in dark at RT. After incubation, the samples
were acquired on BD LSR-II ﬂow cytometer, 10,000 events per
sample were recorded and the dot plots of FLOUS (FL-1 channel)
versus PI (FL-2 channel) were recorded and data analysis was
carried out using BD FACS DIVA software (Islamuddin et al.,
2014).
Analysis of DNA Fragmentation by TUNEL Assay
DNA fragmentation in the bioactive fractions treated (500 μg
ml−1) and untreated parasites was detected by TUNEL assay
according to the manufacturer’s instructions (Apo direct Kit,
Roche). Brieﬂy, stationary phase parasites (2 × 106 ml−1) were
treated with PNHand PNE (500μgml−1) along with appropriate
controls for 72 h at 22◦C. After incubation, the parasites
were harvested and processed as described previously (Chouhan
et al., 2015), following which the cells were incubated in buﬀer
containing nucleotide mix (1 h in a humidiﬁed atmosphere at
37◦C) provided with the kit. The promastigotes were ﬁnally
washed and resuspended in PBS and acquired on BD LSR-II ﬂow
cytometer. The data was acquired (10,000 events per sample) in
the form of histograms and quadrant statistics were calculated
using BD FACS DIVA software.
Determination of Sub G0/G1 Population
The sub G0/G1 population was estimated by staining with PI
according to Sarkar et al. (2008). The bioactive fractions treated
(500 μg ml−1, 72 h, 22◦C) or untreated promastigotes were
harvested, ﬁxed in 80% chilled ethanol and stored at 4◦C (for at
least 24 h) prior to incubation with RNase (200 μg ml−1, 37◦C,
1 h) and further stained with PI (50 μg ml−1) for 20 min in dark
at 22–25◦C. The cells were acquired on BD LSR II ﬂow cytometer.
For each sample, 10,000 events were recorded and the cell cycle
distribution was analyzed using BD FACS DIVA software.
Estimation of MMP, m
Changes in m were determined according to Chandrasekaran
et al. (2013) with few modiﬁcations by staining with JC-
1 (5,5′,6,6′-tetrachloro-1,1′ ,3,3′-tetraethylimidacarbocyanine iod
ide). The diﬀerential ﬂuorescence patterns exhibited by JC-1
enable us to determine relative m of a cell. In live cells, the dye
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accumulates inside the mitochondria forming J-aggregates which
ﬂuoresce red at 590 nm whereas, in cells undergoing apoptosis
the dye is no longer retained inside mitochondria and enters
cytoplasm where it ﬂuorescence green at 530 nm. Thus, red/green
ratio or ﬂuorescence intensity at 590/530 tells us about relative
mof the cell. Brieﬂy, L. donovani promastigotes (2× 106 ml−1)
were treated with the bioactive fractions (500 μg ml−1, 72 h,
22◦C) along with standard controls. Post treatment, the cells
were washed twice and stained with 10 μg of JC-1 for 10 min at
37◦C. The cells were again washed with PBS before acquisition
in BD LSR II ﬂow cytometer. For each sample 10,000 events
were recorded, and quadrant dot plots (red, y-axis versus green,
x-axis) were then generated to distinguish J-aggregates (red
ﬂuorescence) from JC-1 monomers (green-ﬂuorescence) using
BD FACS DIVA software. The ratio of J aggregates/monomers
(red/green) was then plotted to estimate relative m of a cell.
Assessment of ROS Generation
2′, 7′- dichlorodihydroﬂuorescein-diacetate (H2DCFDA)
staining was performed to detect intracellular ROS generation
as described previously (Chouhan et al., 2015). L. donovani
promastigotes (2 × 106 cells ml−1) were cultured in the presence
of PNH, PNE, PIP, pentamidine (500 μg ml−1) or medium
alone at 22◦C for 72 h. Cells were then washed twice with
PBS, incubated with 10 μM of H2DCFDA in dark at RT for
15 min, and ﬁnally acquired in BD LSR II ﬂow cytometer, where
MFI for each sample was recorded. 10,000 events for each
sample were acquired, and histogram analysis of FL-1H (x-axis,
green ﬂuorescence) was performed. On the basis of negatively
(untreated) and positively (pentamidine treated) stained cell
populations, appropriate region was gated to calculate the MFI.
Evaluation of L. donovani Parasite Burden In Vivo
Six to eight weeks old female BALB/c mice were infected with
stationary phase L. donovani promastigotes (2.5 × 107/animal)
via tail vein. Following 10 weeks, parasite burden was evaluated
in three arbitrarily selected animals as described previously
(Chouhan et al., 2015), after which the mice were randomly
assorted into diﬀerent groups (n = 5 per group). Infected
mice were treated daily for two weeks (Eissa et al., 2011;
Ferreira et al., 2014) according to dose regimen mentioned
in Table 1 (after prior in vivo standardization studies) except
TABLE 1 | Experimental design for in vivo studies.
Group Regimen
Normal Normal control/Naïve mice (Administered PBS only)
INF Infected control (BALB/c mice infected intravenously (i.v.)
with L. donovani promastigotes and administered PBS)
VC 0.5% dimethylsulphoxide (DMSO) in PBS
AmB AmB administered i.v. at (5 mg/kg bw)
PNH100 PNH administered intraperitoneally (i.p.) at 100 mg/kg bw
PNH200 PNH administered i.p. at 200 mg/kg bw
PNE100 PNE administered i.p. at 100 mg/kg bw
PNE200 PNE administered i.p. at 200 mg/kg bw
PIP 200 Piperine administered i.p. at 200 mg/kg bw
for AmB, a commercially available antileishmanial drug, taken
as positive control for in vivo studies. AmB was administered
intravenously for 5 days, alternatively at the mentioned dose
(Table 1). Two weeks post-treatment; the mice were bled and
euthanized for determining the therapeutic eﬃcacy along with
immunostimulatory potential and toxicity proﬁle. Impression
smears of liver and splenic tissue were prepared to ascertain
the parasitic load in terms of Leishman-Donovan units (LDU)
according to the formula (Bradley and Kirkley, 1977).
No. of amastigotes
No. of macrophages
× organ weight (mg)
Further, percent protection rendered by PNH, PNE, and other
groups was calculated according to the formula:
LDUinfected control − LDUtreated
LDUinfected control
× 100
Preparation of Leishmanial Antigens
Leishmanial freeze thawed antigen (FT) was prepared from
stationary phase promastigotes (108 ml−1) which were washed
twice with PBS and subjected to six cycles of alternate freezing
(–70◦C, 30min) and thawing (37◦C, 15min). Soluble leishmanial
antigen (SLA) was prepared in similar manner with few
additional modiﬁcations according to Ryan et al. (2002). Parasites
(108 ml−1) were subjected to eight cycles of freezing and
thawing under the above mentioned conditions followed by
centrifugation (5250 × g, 30 min). The resultant supernatant was
separated and protein concentration determined by Folin and
Lowry method (Lowry et al., 1951). The antigens were stored
at –70◦C until use.
Measurement of DTH
Delayed type hypersensitivity (DTH) wasmeasured 2 weeks post-
treatment in all the experimental animals. Brieﬂy, right hind
footpad of mice received FT (800 μg ml−1, 50 μl) whereas
the left hind foot pad was injected with PBS. After 24 h of
antigen inoculation, footpad swelling was measured, and the
DTH response was determined as the diﬀerence in the footpad
swelling between two hind foot pads according to formula
(Banerjee et al., 2008):
Foot pad swelling (mm) = Thicknessright food pad −
thicknessleft foot pad
Lymphoproliferation Assay by CFSE Labeling
In vitro recall responses were studied in lymphocytes isolated
from spleen of untreated and treated animals, post 2 weeks of
treatment. Single cell suspension of spleen cells was prepared
as described previously (Chouhan et al., 2015), following which
cells were re-suspended at 5 × 106 cells ml−1 in serum free
(incomplete) Rosewell Park Memorial Institute (RPMI)-1640
medium supplemented with 100 μg ml−1 streptomycin sulfate,
100 U ml−1 penicillin G-sodium, 0.2% sodium bicarbonate, and
25 mM HEPES. The cells were labeled with CFSE (1 μM) in
dark at RT (Del-Rey et al., 2007). Following incubation, ice-cold
complete RPMI-1640 medium was added to quench the reaction,
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the cells were washed and in vitro re-stimulated with SLA (12 μg
ml−1) or ConA (5 μg ml−1), a non-speciﬁc mitogen that served
as positive control. Normal cells without SLA stimulation were
also seeded to assess the basal level of proliferation. Post 48 h, the
cells were washed twice with PBS before acquisition in BD LSR II
ﬂow cytometer. BD FACS DIVA software was used for analyzing
diﬀerent cell populations.
Determination of Changes in Splenic CD4+ and CD8+
T Cell Numbers
Eﬀect of PNH and PNE on splenic CD4+ and CD8+ T
cell populations was ascertained two weeks post treatment as
described elsewhere (Pathak and Khandelwal, 2009). Brieﬂy,
single cell suspension (2 × 106 per tube) of splenic lymphocytes
was washed twice with FACS buﬀer (1% BSA in PBS) and
co-stained with a cocktail of monoclonal antimouse-CD4-PE and
antimouse-CD8-FITC antibodies (BD biosciences, USA) at 1:200
dilution for 15 min in dark on ice. The cells were washed twice
and ﬁnally acquired in BD LSR II ﬂow cytometer. Single color
controls and suitable isotype controls were also included to rule
out any background ﬂuorescence, for appropriate gating and
positioning of quadrants. Respective percentages of CD4+ and
CD8+ cells were determined using BD FACS DIVA software.
Estimation of Th1/Th2 Cytokines
The levels of INF-γ, TNF-α, IL-2 (Th1), as well as IL-4 and
IL-10 (Th2) cytokines in culture supernatants of splenocytes
were estimated using BD cytometry bead array kit. Post 48 h of
SLA stimulation, culture supernatants from all the experimental
groups were collected and processed for analysis of Th1/Th2
cytokines according to the manufacturer’s instructions using BD
LSR II ﬂow cytometer (Pourrajab et al., 2012).
Estimation of Serum Immunoglobulin G (IgG)-2a and
IgG1 Levels
Serum levels of IgG isotypes, IgG2a and IgG1 were determined
in treated or untreated mice through ELISA according to
Bhowmick et al. (2014) with few modiﬁcations. Brieﬂy, 96 well
U-bottom plates were coated with leishmanial antigen FT (25 μg
ml−1) and left overnight at 4◦C. The unbound antigen was
removed and plates were then blocked with blocking buﬀer
(1% BSA in PBS), for 3–4 h at RT followed by washing (PBS
+ 0.05% Tween-20, 2 × 3 times) and overnight incubation
with primary antibody (mice sera, 1: 1000) at 4◦C. After
washing, the plates were incubated with secondary antibodies,
goat anti-mouse IgG2a and IgG1 (Sigma), followed by washing
and incubation with tertiary antibody, i.e., rabbit anti-goat IgG
conjugated with horseradish peroxidase (1: 10,000). The substrate
solution (o-phenylenediamine dihydrochloride, 0.8 mg ml−1 in
phosphate citrate buﬀer, pH 5.0, containing 0.04% H2O2) was
added after appropriate washing. After 10 min of incubation, the
absorbance measured at 450 nm in an ELISA plate reader.
Analysis of Changes in Expression of CD80/CD86
Co-stimulatory Molecules
Phenotyping of co-stimulatory molecules (CD80 and CD86)
was performed by surface staining of murine peritoneal
macrophages from treated or untreated mice as described
previously (Chouhan et al., 2015). 2 × 106 macrophages per
sample were washed twice with FACS buﬀer and co-stained
with APC conjugated antimouse-CD80, antimouse-CD86-PeCy7
(1: 200 dilution) for 15 min in dark at RT. Suitable controls
including single color and isotype controls were accordingly
prepared to negate any background ﬂuorescence, adjustment
of compensation and to assess staining intensity. A total of
50,000 events were acquired and percentages of cells positive
for CD80 and/or CD86 were calculated after proper gating and
analysis.
Estimation of NO Production in BALB/c Mice
Splenocytes
Nitric oxide was estimated in culture supernatants of SLA
stimulated or unstimulated splenocytes after 48 h of culture
using Griess reagent as described elsewhere (Roychoudhury et al.,
2011). Sodium nitrite was used to generate a standard curve and
nitrite concentration was calculated using speciﬁc OD values at
540 nm, generated in triplicates.
Assessment of Hepatic and Renal Toxicity
The toxicity proﬁle was tested in infected as well as treated mice
(ﬁve per group). The mice were administered bioactive fractions,
PIP, and AmB at previously indicated doses (Table 1) for 2 weeks.
Two weeks post-treatment, the mice were bled and sera were
separated and stored at –70◦C. Serum levels of liver enzymes
such as SGPT, SGOT, ALP, and serum concentrations of urea
and creatinine to ascertain renal toxicity were estimated using
commercially available kits (Span Diagnostics Ltd., Surat, India)
according to the manufacturer’s instructions (Islamuddin et al.,
2014).
Flow Cytometry Analysis
All the ﬂow cytometry data was acquired on BD LSR II
ﬂow cytometer. For all in vitro and in vivo experiments
10,000 and 50,000 events were acquired, respectively. Cell
debris, characterized by a low side scattered light (SSC)/forward
scattered light (FSC) was excluded from analysis. All the analyses
were carried out using BD FACS DIVA software.
Statistical Analysis
All in vitro experiments were performed at least thrice and
the results represented are from one of the three independent
experiments and expressed as mean ± SEM of the samples
in triplicate. The in vivo study was carried out twice
with ﬁve mice per group, and the results shown are from
one of the two independent experiments and expressed as
mean ± SEM. Statistical analysis was performed using Graph-
Pad Prism 5 software and the statistical signiﬁcance was
calculated by ANOVA followed by Tukey’s multiple comparison
test. Diﬀerences were considered statistically signiﬁcant at
P < 0.05. Statistical signiﬁcance is indicated with the help of
appropriate symbols in graphs or explained in respective result
section.
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RESULTS
Detection of Apoptosis in L. donovani
Promastigotes by Bioactive Fractions
Visualization of PS Externalization
PS externalization as a characteristic attribute of apoptosis was
examined in PNH and PNE treated samples. Percentage of
apoptotic, necrotic, late, or secondary apoptotic and live cells
were deduced from quadrant statistics. 21.0% and 17.7% of
treated promastigotes became Annexin positive in case of PNH
and PNE, respectively (Figures 1A,B). A small proportion of
late apoptotic cells (both Annexin and PI positive, 1.7% in
PNH, 0.7% in PNE) along with apoptotic cells (PI positive, 2.4%
in PNH, 0.1% in PNE) were also observed, which indicated
compromised membrane integrity. In case of pentamidine, 45.4%
cells were observed to be apoptotic whereas 28.4% cells were
found to be secondary apoptotic. 2.5% cells underwent apoptosis
following treatment with PIP whereas apoptotic toll in control
parasites was 0.6%. Thus our data indicates that the mode
of induced cell death by the bioactive fractions was primarily
apoptosis.
Assessment of DNA Fragmentation
Apoptosis is characterized by rapid DNA fragmentation,
which can be quantiﬁed ﬂow cytometrically by TUNEL assay.
Treatment with PNH and PNE resulted in nuclear DNA
fragmentation as evidenced by an increase in dUTP-FLOUS
labeling (Figures 2A,B). In PNH and PNE treated samples, MFI
increased to 583 (P < 0.001) and 522 (P < 0.001), respectively,
in comparison with parasite control (MFI = 78), respectively.
PIP treated promastigotes exhibited a non-signiﬁcant increase
in MFI (MFI = 88, P > 0.05) whereas pentamidine treated
promastigotes underwent extensive DNA fragmentation
(MFI = 666, P < 0.001).
Cell Cycle Analysis
Cell cycle analysis unveils distribution of cells in diﬀerent
interphase stages based on their DNA content. The cells with
fragmented DNA as a result of any treatment are detected in
sub G0–G1 phase, which is indicative of apoptosis. In PNH and
PNE treated samples, 30.1% (P < 0.001) and 23.7% (P < 0.001)
cells underwent apoptosis whereas in PIP treated samples, only
3.6% ± 0.4 cells were found to be apoptotic (P > 0.05). In
FIGURE 1 | Visualization of PS exposure. (A) Promastigotes (2 × 106 ml−1) after treatment with test fractions and compounds (500 μg ml−1) for 72 h at 22◦C
were co-stained with Annexin-V-FLUOS and PI. The bar graph depicts percentages of live, apoptotic, secondary apoptotic and necrotic cells for different test
samples. ∗∗∗P < 0.001 and ∗∗P < 0.01 with respect to parasite control. (B) FL-1 (x-axis) vs. FL-2 (y-axis) dot plots depicting live (both annexin and PI negative,
lower left quadrant), necrotic (PI positive, upper left quadrant), apoptotic (annexin positive, lower right quadrant) and secondary necrotic (both annexin and PI postive)
Leishmania parasites.
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FIGURE 2 | Study of apoptotic correlates post-treatment with bioactive fractions. (A) DNA fragmentation in treated promastigotes illustrated by TUNEL
assay. The promastigotes (2 × 106 ml−1) were treated with bioactive fractions and compounds (500 μg ml−1) for 72 h at 22◦C after which the cells were processed
according to manufacturer’s instructions and acquired on BD LSR II flowcytometer. Histograms depict shift in MFI of (b) PNH, (c) PNE, (d) piperine, and (e)
pentamidine with respect to (a) parasite control. (B) Bar graph representing the specific MFI values indicative of TUNEL positivity in PNH, PNE and pentamidine
treated samples. ∗∗∗P < 0.001 and ns = non-significant with respect to parasite control. (C) Detection of sub G0-G1 or apoptotic population. Promastigotes
(2 × 106 ml−1) were untreated or treated (500 μg ml−1, 72 h, 22◦C) with bioactive fractions and processed for cell cycle analysis as described in methods.
pentamidine treated samples 28.2% ± 1.15 (P < 0.001) turned
apoptotic whereas in parasite control only 0.4% ± 0.55 cells were
detected in sub G0–G1 phase (Figure 2C).
Determination of Changes in m
Since Leishmania parasites possess a single mitochondrion, the
loss of m and subsequent activation of apoptosis cascade
becomes detrimental to the survival of organism. The changes
in m can be well depicted by staining with JC-1 whose
diﬀerential ﬂuorescence patterns inside (red) and outside (green)
of mitochondria represent changes in m. Typically, m is
represented as ratio of ﬂuorescence at 590/530 nm or red/green
ﬂuorescence where a decrease in the ratio indicates loss of
m. In our study, PNH and PNE induced mitochondrial
membrane depolarization (Figure 3A) as evidenced by decrease
in 590/530 nm ratio in PNH (3.86 ± 0.45), PNE (4.85 ± 0.69),
and pentamidine treated samples (0.84 ± 0.08) whereas PIP
treatment induced non-signiﬁcant changes in m (13.35 ± 0.69)
with respect to parasite control.
Estimation of ROS Generation
ROS, an important mediator in induction of apoptosis was
probed by staining with H2DCFDA, which upon cleavage
with free radicals generates green ﬂuorescence. In control
promastigotes without any treatment, basal level of ROS was
detected (MFI = 3381 ± 50) whereas a sharp shift in MFI
(P < 0.001) of PNH and PNE treated samples corresponding
to 9027 ± 250.5 and 8072 ± 394, respectively (Figure 3B)
indicated generation of ROS. PIP induced an insigniﬁcant shift
in green ﬂuorescence (MFI = 3735 ± 130, P > 0.05) whereas
in pentamidine treated promastigotes, enhanced ROS production
was well apparent (MFI = 10037 ± 401.5, P < 0.001).
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FIGURE 3 | Effect of Piper nigrum bioactive fractions on intracellular events leading to apoptosis. (A) Study of mitochondrial membrane depolarization.
Leishmania donovani promastigotes (2 × 106 ml−1) were incubated with different bioactive fractions or test compounds (500 μg ml−1, 72 h, 22◦C) and stained with
JC-1 as described in methods. ∗∗∗P < 0.001 and ∗∗P < 0.01 in relation to parasite control. (B) ROS generation upon bioactive fractions treatment. ROS generation
was monitored in L. donovani promastigotes (2 × 106 ml−1) post 72 h of treatment (500 μg ml−1) with different bioactive fractions. Following acquisition of
H2DCFDA stained parasites, the histograms were plotted where P2 gated region depicts shift in MFI. The shift in MFI was significant in case of PNH, PNE, and
pentamidine (P < 0.001) and non-significant in case of piperine (P > 0.05) as indicated in results.
In Vivo Antileishmanial and
Immunomodulatory Potential of
Bioactive Fractions
Reduction in Parasite Burden and
Hepatosplenomegaly
In vivo antileishmanial eﬃcacy of P. nigrum bioactive fractions
was assessed in L. donovani infected BALB/c mice. Infected
control and vehicle treated animals displayed heavy parasite
burden. LDU equated to 1107.95 and 131.50 in liver and
spleen, respectively, in INF group whereas in VC group, LDU
corresponded to 1010.53 (liver) and 122.24 (spleen). PNH
(200 mg/kg bw) caused substantial reduction in parasite load
in both liver (LDU = 111.80, 89.9% protection, P < 0.001)
and spleen (LDU = 17.52, 86.66% protection, P < 0.001). PNE
(200 mg/kg bw) also considerably reduced the parasite burden
(P < 0.001), in liver (LDU = 247.52, 87.76% protection), and
spleen (LDU = 34.02, 85.55% protection). At lower doses, PNH
at 100 mg/kg bw partially but signiﬁcantly reduced the LDU
to 482.48 (P < 0.05) and 65.85 (P < 0.05) in liver and spleen,
respectively, with percent protection corresponding to 56.44%,
and 49.93% for liver and spleen, respectively. 100 mg/kg bw of
PNE treatment was the least eﬀective in reducing parasite burden
with LDU= 520.26 (liver, P < 0.05), and 70.65 (spleen, P < 0.05)
conferring percent protection equivalent to 39.65 and 35.93% in
liver and spleen, respectively. At 200mg/kg bw, PIP also exhibited
partial protection (P < 0.05), with protection levels of 55.86 and
49.93% for liver and spleen, respectively. For, AmB treatment
percent protection corresponded to 95.97% (liver, P < 0.001) and
91.84% (spleen, P < 0.001), respectively, (Figure 4A).
The notable reduction in parasite burden following bioactive
fractions was also accompanied by restoration of liver and spleen
weights to normal range. INF and VC group animals exhibited
signiﬁcant elevation (P < 0.001) in liver and spleen weight in
comparison to uninfected mice, which were successfully restored
to normal levels by AmB as well as by PNH (200 mg/kg bw)
treatment. PNE (200 mg/kg bw) treatment also declined the
hepatic (P < 0.001) and splenic weights (P < 0.01), followed
closely by PIP treatment, which also demonstrated similar eﬀect
(P < 0.05), whereas changes after PNE 100 mg/kg bw treatment
were less apparent (P > 0.05) (Figure 4B).
DTH Response Post Treatment with PNH and PNE
A positive DTH reaction symbolizes successful recovery from
VL without relapse in infection and activation of CMI. Thus,
DTH was evaluated in L. donovani infected BALB/c mice post
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FIGURE 4 | In vivo therapeutic potential of P. nigrum bioactive fractions. (A) Estimation of parasite burden in untreated and bioactive fractions treated mice.
VC = vehicle control (0.5% DMSO in PBS), INF = Infection control, AmB = AmB at 5 mg/kg bw, PNH100 = P. nigrum hexane fraction at 100 mg/kg bw,
PNH200 = P. nigrum hexane fraction at 200 mg/kg bw, PNE100 = P. nigrum ethanolic fraction at 100 mg/kg bw, PNE200 = P. nigrum ethanolic fraction at
200 mg/kg bw and PIP200 = Piperine at 200 mg/kg bw. L. donovani infected BALB/c mice were either untreated or subjected to different treatments followed by
estimation of hepatic and splenic parasite burden as described in methods. ∗∗∗P < 0.001, ∗∗P < 0.01, and ∗P < 0.05 in relation to INF group. (B) Differences in liver
and spleen weights amongst various experimental groups. The dotted line represents average weight of respective organs in normal mice. #P < 0.001 in
comparison to naive mice, for rest ∗∗∗P < 0.001, ∗∗P < 0.01, ∗P < 0.05, and ns = non-significant with respect to INF.
treatment with bioactive fractions, after 2 weeks interval. PNH
(200 mg/kg bw) treated animals exhibited the highest DTH
response which was ∼5.2-fold (P < 0.001) higher than infected
mice. PNE treatment at 200 mg/kg bw also resulted in signiﬁcant
enhancement in DTH response of ∼3.49-fold (P < 0.001).
Induction in DTH response was less potent and partial at
100 mg/kg bw dose of PNH, PNE and PIP (P > 0.05) whereas
AmB treatment resulted in substantial elevation (∼3.49-fold,
P < 0.001) in DTH response (Figure 5).
Effect of Bioactive Fractions on Proliferative Capacity
of Splenocytes after In Vitro Restimulation with SLA
During progression of VL, T cells become inert to leishmanial
antigens with subsequent suppression of their proliferative
capacity and successful treatments are often capable of restoring
the defective T cell responses. To assess the magnitude of
lymphoproliferation post PNH and PNE treatments, splenocytes
were labeled with CFSE. In general, CFSE ﬂuorescence becomes
half of its original after each cell division, thus a shift in
CFSE ﬂuorescence toward left of the x-axis indicates cell
proliferation. Marginal numbers of CFSE positive population
was observed in normal cells with or without SLA stimulation
(Figure 6) indicating basal level of proliferation. Post-SLA
stimulation, strong lymphoproliferative responses were evident
in PNH and PNE treated groups. Signiﬁcantly enhanced
levels of CFSE positive populations were detected in PNH
(48.4% ± 5.39, P < 0.001) and PNE (44.8% ± 2.97,
P < 0.01) treated groups, respectively, at 200 mg/kg bw
in comparison to INF (23.2% ± 3.52). At 100 mg/kg bw,
lymphoproliferative responses were only partially stimulated
(P > 0.05) with 30.2% ± 6.09, and 21.8% ± 4.12 CFSE
positive cells observed in PNH and PNE treated samples,
respectively. Only 28.9% cells underwent proliferation with
PIP treatment and the extent of response was insigniﬁcant
in comparison to INF group (P > 0.05). AmB speciﬁcally
enhanced in vitro recall response after SLA stimulation
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FIGURE 5 | Evaluation of DTH response. After two weeks of treatment,
animals were either inoculated with FT or PBS alone in hind footpads and
DTH was measured post 24 h as described in methodology section.
∗∗∗P < 0.001 and ns = non-significant in comparison to INF.
(47.6%± 2.64). ConA stimulation also resulted in signiﬁcant level
of proliferation with percentage of CFSE positive cells leaping up
to 50.2% ± 1.47.
Analysis of Changes in Splenic CD4+ and CD8+ T
Populations
Both CD4+ and CD8+ T cell populations are known to induce
parasite clearance by initiating Th1 biased immune response.
The phenotypic analysis of CD4+ and CD8+ expression
revealed that P. nigrum bioactive fractions enhanced T cell
subpopulations (Figures 7A,B). Expression of both CD4+ and
CD8+ T cells was downregulated in INF group to 22.0% ± 2.1
(CD4+), and 7% ± 1.2 (CD8+) in comparison to naïve
mice (CD4+ = 24.1% ± 1.6, CD8+ = 11% ± 1.9). CD4+ T
cell population was elevated to 36.4% ± 1.80 (P < 0.001)
and 30.5% ± 2.3 (P < 0.05), respectively, in case of PNH
and PNE at 200 mg/kg bw treatment. At 100 mg/kg bw of
PNH and PNE, the changes were less pronounced and CD4+
population was restored to normal values of 27.3% ± 2.4
and 24.9% ± 3.7 (P > 0.05), respectively. PIP treatment
resulted in modulation of CD4+ expression in normal range
(27.5% ± 1.8, P > 0.05) whereas AmB treatment signiﬁcantly
upregulated the number of CD4+ positive cells to 37.0% ± 2.2
(P < 0.001).
PNH at both the doses (100 and 200 mg/kg bw) restored the
CD8+ T cell numbers to normal range with 12%± 4.7 (P < 0.05)
and 12.4% ± 3.32, (P < 0.01), respectively. PNE at 100 and
200 mg/kg bw resulted in insigniﬁcant immunomodulation with
11.5% ± 1.86 and 9.7% ± 0.8 (P > 0.05) CD8+ expression,
respectively. PIP and AmB treatment resulted in restoration of
CD8+ population to normalcy, 10.3% ± 1.25 and 10.4% ± 2.16
(P > 0.05) respectively.
Determination of Changes in Th1/Th2 Cytokine
Levels
The outcome of VL is largely dependent upon the cytokine
milieu. Th2 cytokines dominate the diseased state whereas
Th1 cytokines predominantly characterize the recovery
state. Th1/Th2 cytokine levels were measured in the culture
supernatants of splenocytes stimulated with SLA. PNH at
200 mg/kg bw induced signiﬁcant levels (P < 0.001) of INF-γ,
TNF-α and IL-2 production and waned IL-4 and IL-10 levels
(P < 0.001) in comparison to INF (Figure 8A). PNE (200 mg/kg
bw) partially elevated INF-γ (P < 0.05) and simultaneously
declined IL-4 (P < 0.05) levels. However, there was insigniﬁcant
increase in TNF-α (P > 0.05) and IL-2 (P > 0.05) and less
conspicuous decrease in IL-10 (P > 0.05) levels by PNE in
comparison to INF. PIP (200 mg/kg bw) failed to stimulate
INF-γ, TNF-α and IL-2 production signiﬁcantly (P > 0.05) and
also marginally aﬀected IL-4 and IL-10 production (P > 0.05).
AmB treatment successfully enhanced the production of Th1
cytokines and curtailed Th2 cytokines production (P < 0.001).
Enhancement in Serum IgG2a Levels Post Treatment
with P. nigrum Bioactive Fractions
IgG2a and IgG1 serve as surrogate markers for Th1 and Th2
activation since their production is stimulated by INF-γ and
IL-4, respectively. At 200 mg/kg bw, PNH and PNE treatment
stimulated ∼4.72-fold (P < 0.001) and ∼4.26-(P < 0.01) folds
more IgG2a production with respect to untreated animals
(Figure 8B). PNH and PNE at 100 mg/kg bw induced ∼3.48-
and ∼2.67-folds increase in IgG2a production (P > 0.05).
IgG2a levels were enhanced by ∼3.45-fold (P > 0.05) after
PIP treatment whereas sera from AmB treated mice displayed
maximum induction of IgG2a (∼4.95-fold). IgG1 levels were
signiﬁcantly increased in INF and VC groups (P < 0.001) with
respect to naive mice. IgG1 levels were substantially lowered in
all other treatment groups with lesser variations amongst the two
doses (P < 0.05).
Analysis of Changes in CD80/CD86 Expression
Profile
Co-stimulatory molecules strengthen the T cell-major
histocompatibility complex interaction for proper activation
of T cells thereby substantiating the eﬀector immune response.
Surface phenotyping for CD80 and CD86 expression was
thus performed and changes in CD80 and CD86 expression
were analyzed. In naïve mice, CD80 and CD86 expression
corresponded to 40.5% and 16.0%, respectively (Figure 9A).
CD80 expression was enhanced after treatment (200 mg/kg bw)
with PNH (61.1%, P < 0.001), and PNE (51.8%, P < 0.001)
with respect to INF (36.3%). At 100 mg/kg bw, the CD80
expression was enhanced to 50.5% (PNH, P < 0.001), and
43.2% after PNE (P > 0.05) treatment. AmB treatment
also elevated the CD80 expression to 56.6% (P < 0.001)
whereas in case of PIP treatment elevation was partial (45.4%,
P < 0.05) but signiﬁcant with respect to INF. At 200 mg/kg
bw, CD86 expression was enhanced up to 33.5% (P < 0.001)
and 22.2% (P < 0.01) by PNH and PNE, respectively, in
comparison to INF (14.2%). The bioactive fractions at
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FIGURE 6 | Assessment of lymphoproliferative responses in L. donovani infected BALB/c mice. Post 2 weeks treatment, RBCs free single cell suspension
of splenocytes was labeled with CFSE and in vitro restimulated with SLA. The contour plots depict CFSE fluorescence where a shift in MFI toward left denotes loss
of CFSE labeling and in turn, lymphoproliferation. Percentage of CFSE positive cells in respective samples in the presence or absence of SLA stimulation is indicated.
100 mg/kg bw demonstrated non-signiﬁcant (P > 0.05)
partial modulation of CD86 expression. CD86 expression
was stimulated up to 19.6 and 15.4% in case of PNH and
PNE, respectively. PIP resulted in partial and signiﬁcant
modulation of CD86 expression to 20.8% (P < 0.05) and AmB
treatment particularly enhanced CD86 expression up to 24.5%
(P < 0.01).
Determination of NO Production
Nitric oxide generation is impaired during Leishmania infection,
which is critical for termination of the parasite growth. All
the treatment groups only marginally (P > 0.05) modulated
NO levels except for AmB, which signiﬁcantly upregulated NO
production (P < 0.001). PIP treatment also failed to generate any
signiﬁcant changes in NO levels (P > 0.05) (Figure 9B).
Toxicity Profile of P. nigrum Bioactive Fractions
In Vivo
In vivo adverse toxicity of bioactive fractions was assessed
at 200 mg/kg bw in L. donovani infected mice. The serum
levels of SGOT (P < 0.001), SGPT (P < 0.01), and ALP
(P < 0.001) were particularly enhanced in INF and VC groups
with respect to untreated mice. In all the treatment groups,
the enzyme levels were found in normal range (P < 0.01)
indicating no adverse eﬀect of the bioactive fractions on hepatic
function (Table 2). Renal toxicity was evaluated in terms of
serum levels of creatinine and urea. Colorimetric estimation
revealed that concentration of the metabolites was signiﬁcantly
enhanced in INF and VC group, which was restored to
normal range after treatment with PNH and PNE (P < 0.001).
None of the other groups exhibited signiﬁcant renal toxicity
(P < 0.001). No adverse eﬀects were observed after AmB
treatment.
DISCUSSION
Major ﬁndings emanating from our work are that the remarkable
antileishmanial activity exhibited by PNH and (PNE) fractions
in vitro was interceded via apoptosis and the in vivo therapeutic
potential was accompanied by Th1 stimulation without
any potential toxicity. We have previously reported potent
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FIGURE 7 | Determination of changes in splenic T cell populations. (A) To distinguish CD4+ and CD8+ T cell population, co-staining with anti-CD4-PE and
anti-CD8-FITC antibodies was performed as described in the Section “Materials and Methods”. Bar graphs display significant and non-significant changes in CD4+
and CD8+ T cell numbers post-treatment with bioactive fractions. ∗∗∗P < 0.001, ∗∗P < 0.01, ∗P < 0.05, and ns = non-significant with respect to INF. (B) Dot plots
also depicting the changes in splenic CD4+ and CD8+ T cell numbers after treatment with P. nigrum bioactive fractions.
leishmanicidal activity of PNH and PNE against L. donovani
promastigotes and amastigotes and identiﬁed the plant secondary
metabolites present in PNH and PNE. We have found that PNH
was majorly constituted by trans-β-caryophyllene (22.28%),
whereas PNE was dominantly constituted by PIP (70.36%)
(Chouhan et al., 2014b).
PNH and PNE induced apoptosis in L. donovani
promastigotes which is the preferred mode of cell death.
L. donovani promastigotes are known to undergo apoptosis
in response to various plant extracts and plant secondary
metabolites (Chouhan et al., 2015 and references therein).
Induction of apoptosis by PNH and PNE in L. donovani
promastigotes was evidenced by PS externalization detected by
annexin-PI co-staining, DNA fragmentation demonstrated by
TUNEL assay and cell cycle analysis, depolarization of MMP/m
by JC-1 staining and generation of ROS by H2DCFDA staining.
H2DCFDA is a widely used ﬂuorescent probe for detection of
ROS despite the lack of speciﬁcity. In addition to ROS, it can also
detect other oxidants such as reactive nitrogen species (RNS) in
a cell (Koopman et al., 2006), both of which are however known
to induce apoptosis (Shen and Liu, 2006). Thus, H2DCFDA
staining gives a broad idea about oxidant levels in a cell but
the non-speciﬁcity of the probe makes it diﬃcult to identify
the nature of the oxidants (Wardman, 2007). Since, high level
of oxidants generate oxidative stress that triggers apoptosis
(Yin et al., 2003), it can be concluded that high levels of ROS
detected in PNH and PNE treated promastigotes may have
aided in apoptosis induction. Pentamidine has been in regular
use as a positive control in several antileishmanial studies (dos
Santos et al., 2011; Sawadogo et al., 2012; Benitez et al., 2013)
including earlier studies performed by us (Chouhan et al.,
2014b, 2015; Islamuddin et al., 2014). Since, pentamidine is
also known to induce apoptosis in Leishmania promastigotes
(Singh and Dey, 2007) it was included as positive control for all
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FIGURE 8 | Analysis of Th1 subset potentiation. (A) Estimation of Th1 and Th2 cytokine levels. INF-γ, TNF-α, IL-2, IL-4, and IL-10 were quantified in culture
supernatants of splenocytes post 48 h of SLA stimulation as described in the Section “Materials and Methods”. #P < 0.001 in comparison to normal group,
∗∗∗P < 0.001, ∗∗P < 0.01, and ∗P < 0.05 with respect to INF. (B) IgG isotyping in sera of untreated and differently treated BALB/c mice. Leishmanial antigen
specific IgG2a and IgG1 isotypes were quantified in BALB/c mice serum samples by ELISA. #,indicates significant elevation in IgG1 levels in INF and VC group in
comparison to naïve mice. ∗∗∗P < 0.001, and ∗∗P < 0.01 with respect to INF.
apoptotic studies. Ethanolic extract of P. betle had been shown
to induce apoptosis in L. donovani promastigotes by disrupting
m and causing DNA fragmentation including generation of
nicked DNA and cell cycle arrest by Sarkar et al. (2008). Our
results also indicated that P. nigrum bioactive fractions bore
apoptosis inducing potential in L. donovani promastigotes as
evidenced by Annexin-PI co-staining, TUNEL assay, cell cycle
analysis, study of MMP/m and detection of ROS. Trans-
β-caryophyllene, a major component of PNH is also known to
induce apoptosis in tumor cell lines (Amiel et al., 2012) and
may have contributed to the apoptotic potential of PNH. Several
authors have used Leishmania promastigotes as primary choice
for rapid drug screening and also for elucidation of apoptosis
related phenomena in place of ‘amastigotes’ which are clinically
relevant stage of the parasite (Machado et al., 2012; Sifaoui et al.,
2014; Sousa et al., 2014; da Silva et al., 2015). Though, here we
have demonstrated apoptosis inducing capacity of our bioactive
fractions, a more deﬁnitive conclusion can only be obtained by
further assessing the apoptosis inducing potential of PNH and
PNE in L. donovani amastigotes.
In vivo antileishmanial and immunomodulatory potential of
P. nigrum bioactive fractions was appraised in vivo in BALB/c
mice. BALB/cmice are highly susceptible to L. donovani infection
(Rolao et al., 2003) and have been proven to be immensely
useful for illumination pertaining to pathogenesis and resolution
of disease (Mahmoudzadeh-Niknam et al., 2007). PNH and
PNE at 200 mg/ kg bw rendered remarkable protection whereas
partial recovery from disease was evident at 100 mg/kg bw
dose. Despite several antileishmanial studies from numerous
plants of the genus Piper (Torres-Santos et al., 1999; Hermoso
et al., 2003; Bodiwala et al., 2007; Sarkar et al., 2008; Flores
et al., 2009; Rodrigues-Silva et al., 2009; Monzote et al., 2010;
Cruz et al., 2011; Carrara et al., 2013), there are no reports on
in vivo antileishmanial potential of P. nigrum extracts or pure
compounds isolated from P. nigrum to the best of our knowledge.
However, in vivo antileishmanial eﬃcacy of PIP and its diﬀerent
formulations have been earlier reported. Veerareddy et al. (2004)
demonstrated low curative eﬃcacy of PIP in comparison to its
lipid nanosphere formulation in L. donovani infected BALB/c
mice. Similarly in hamster model also, free PIP was found to
be less eﬀectual than its mannose-coated liposomal formulation
in resolving VL infection (Raay et al., 1999). In our studies, we
also observed that PIP rendered moderate protection in vivo and
was less eﬀectual in comparison to PNH and PNE. We have
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FIGURE 9 | Assessment of immunomodulatory effect of bioactive fractions on murine macrophages. (A) Estimation of CD80 and CD86 expression.
Peritoneal macrophages from different treatment groups were exposed to surface staining with antimouse-CD80-APC and antimouse-CD86-PeCy7 along with
appropriate controls. Individual percentages of CD80 and CD86 positive cells for each group were deduced with the help of BD FACS DIVA software. ∗∗∗P < 0.001,
∗∗P < 0.01, ∗P < 0.05, and ns = non-significant with respect to INF. (B) Assessment of in vivo NO production. Culture supernatants from splenocytes of all the
experimental groups were isolated and incubated with equal volume of griess reagent for NO estimation as described in methodology section. ∗∗∗P < 0.001 and
ns = non-significant with respect to INF.
already established superior eﬃcacy of PNH and PNE over PIP
against L. donovani promastigotes (Chouhan et al., 2014b) and
previous in vitro studies in this regard have also pointed out
that PIP is more eﬃcacious against L. amazonensis (new world
species) rather than L. donovani (Kapil, 1993; Singh et al., 2010;
Ferreira et al., 2011). However, it is also likely that moderate
antileishmanial eﬃcacy exhibited by PIP may have compounded
the leishmanicidal activity of PNH and PNE.
The therapeutic cure by P. nigrum bioactive fractions
was steered by Th1 polarization (Summarized in Figure 10).
P. nigrum hosts numerous biological activities including
immunomodulatory where it has been shown to exhibit typical
Th1 favoring potential including splenocyte lymphoproliferation
and upregulation of Th1 cytokines (Majdalawieh and Carr,
2010). In accordance, with these earlier ﬁndings, our data also
elaborated the potent immunostimulatory potential of P. nigrum
bioactive fractions that might have augmented their in vivo
therapeutic potential. AmB used as a positive control for in vivo
experiments, is known to be immunomodulatory (Reyes et al.,
2000) coupled to its antileishmanial activity. In experimental
VL, AmB has been demonstrated to induce lymphoproliferation
and NO production, elicit DTH, and alter IgG isotype levels in
L. donovani infected BALB/c mice (Banerjee et al., 2008).
PNH and PNE (200 mg/kg bw) treated mice displayed strong
DTH responses which were weaker at 100 mg/kg bw and in
PIP treated group. DTH reaction is elicited in response to
parasite invasion and aids in elimination of the pathogen (Kaur
et al., 2010) as well as in the context of VL it denotes full
recovery from infection with lesser risk of relapse (Grimaldi
and Tesh, 1993). Leishmania parasites paralyze host immunity
in more than one ways and depression of T cell proliferative
responses is very common during the infection period (Carvalho
et al., 1994). Treatment with PNH and PNE (200 mg/kg bw)
abrogated the T cell anergy and strong in vitro recall responses
were evident in response to restimulation of splenocytes with
SLA. Lymphoproliferative responses were less pronounced in
case of PIP and at 100 mg/kg bw dose of PNH and PNE.
Conventionally, CD4+ T lymphocytes were considered more
crucial in containing leishmaniasis but of late, important
participatory role of CD8+ T lymphocytes in clearing Leishmania
infection has been demonstrated (Beattie et al., 2010; Kaushal
et al., 2014). L. donovani is known to suppress the expansion
and eﬀector function of CD4+ and CD8+ cells during the
course of disease (Joshi et al., 2009; Esch et al., 2013). PNH and
PNE signiﬁcantly enhanced CD4+ population at 200 mg/kg bw
whereas at 100 mg/kg bw the CD4+ expression was restored
to normal range. Changes in CD8+ T cell population varied
amongst the diﬀerent treatment groups. While PNH signiﬁcantly
upregulated the number of CD8+ T lymphocytes in comparison
to INF group, such changes were less apparent in AmB and
PIP treated groups. The elevation in CD8+ population after
PNE treatment at 200 mg/kg bw was comparatively less than
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FIGURE 10 | Postulated mechanism for in vivo efficacy of P. nigrum bioactive fractions. The figure depicts that during the course of L. donovani infection in
BALB/c mice, the immune response was tilted toward Th2 type. The co-stimulatory molecules CD80 and CD86 were downmodulated and NO production was
suppressed. CD4+ and CD8+ T cell numbers also declined and the immune response was driven toward Th2 type under the influence of elevated IL-4 and IL-10
levels leading to parasite survival characterized by negative DTH and only basal levels of lymphoproliferation. This immune containment was reversed following
treatment with P. nigrum bioactive fractions. The CD80–CD86 expression was elevated, NO was enhanced, and splenic CD4+ and CD8+ T numbers were also
augmented. Enhanced secretion of proinflammatory cytokines (INF-γ, TNF-α, and IL-2) further strengthened the Th1 potentiation as was evident from positive DTH
and strong lymphoproliferative response and led to parasite killing.
that observed at 100 mg/kg bw. This may be attributed to
the fact that pro- or anti-immunopotentiating eﬀects of natural
immunomodulators can be dose dependent (Spelman et al., 2006)
and has also been evidenced earlier in case of other plant extracts
(SaiRam et al., 1997).
Cytokine milieu in VL is muddled and anti-inﬂammatory
or Th2 cytokines dominate the diseased state whereas cure is
propelled by secretion of Th1 or pro-inﬂammatory cytokines.
Treatment with PNH elevated INF-γ, TNF-α, and IL-2 levels
whereas PNE exhibited variable eﬀect. PNE did not signiﬁcantly
elevate TNF-α and IL-2 but enhanced INF-γ levels. INF-γ
is a characteristic pro-inﬂammatory cytokine, which activates
macrophages and also promotes the class switching of B cells
to produce more of IgG2a. INF-γ is known to work in synergy
with both TNF-α and IL-2 in maintaining a Th1 polarized
environment (Sharma et al., 2012), TNF-α is also known to
TABLE 2 | Estimation of serum levels of liver enzymes and kidney metabolites.
Groups SGOT (U/L) SGPT (U/L) ALP (KA) Creatinine (mg/dl) Urea (mg/dl)
Normal 24.09 ± 3.64 33.69 ± 6.33 8.49 ± 0.43 1.05 ± 0.12 26.19 ± 1.87
INF 69.00 ± 4.49 81.67 ± 4.5 12.99 ± 0.98 3.41 ± 0.36 63.15 ± 0.57
VC 66.32 ± 5.46 80.16 ± 2.06 11.32 ± 0.89 2.99 ± 0.57 67.89 ± 4.56
AmB 27.72 ± 4.78 59.51 ± 6.30 4.15 ± 0.50 1.53 ± 0.36 33.54 ± 6.92
PNH200 23.18 ± 5.01 46.54 ± 7.33 5.96 ± 0.67 1.36 ± 0.18 34.65 ± 9.96
PNE200 31.50 ± 7.56 53.45 ± 5.66 5.23 ± 0.99 1.34 ± 0.22 38.33 ± 8.56
PIP200 26.95 ± 3.11 35.83 ± 3.90 5.61 ± 0.67 1.24 ± 0.39 29.54 ± 9.82
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induce macrophage’s NADPH oxidase and aids in macrophage
activation (Diaz-Gandarilla et al., 2013). IL-4 and IL-10 levels
were also downregulated after bioactive fractions treatment
and PNH treatment remarkably declined IL-10 secretion. The
stimulation of IgG2a and a concomitant decrease in IgG1
levels after bioactive fractions treatment can be well correlated
with enhanced INF-γ production and suppression of IL-4
secretion by PNH and PNE. IL-10 has been designated as master
puppeteer in VL exacerbation. Though, in murine and human
VL, INF-γ is produced in suﬃcient amounts, IL-10 is known to
override Th1 stimulatory capabilities of INF-γ by suppressing its
production, macrophage activation, downmodulating CD80 and
CD86 expression and impairing other accessory cell functions
(Couper et al., 2008).
The interaction between T cell and major histocompatibility
complex is cemented by co-stimulatory molecules including
CD80 and CD86. CD80–CD86 expression that was
downregulated during infection was revived by treatment
with PNH and PNE as well as PIP reﬂecting that bioactive
fractions treatment enhances the ability of macrophages to
present leishmanial antigens to T cells. Same has been observed
earlier in case of treatment with miltefosine and pyrazinamide
(Mendez et al., 2009; Mukhopadhyay et al., 2011).
Nitric oxide induction is another parameter, which indicates
Th1 potentiation as it is produced by NOSII activated by
Th1 cytokines. P. nigrum bioactive fractions along with PIP
did not signiﬁcantly enhance the NO production. Although,
there is no dearth of evidence depicting crucial role of NO
in killing intracellular Leishmania parasites but there are
multifarious reports indicating that INF-γ dependent NOSII or
NO independent leishmanicidal pathways also exist (Bogdan,
2007 and references therein). This may also be true in case of
parasite death induced by P. nigrum bioactive fractions. Further,
trans-β-caryophyllene (major component in PNH) has been
reported to be active against L. amazonensis amastigotes in an
NO-independent manner (Soares et al., 2013). PIP also failed to
induce NO production and similar observation has been reported
by others. PIP though inhibited the growth of L. amazonensis
amastigotes but failed to induce NO production (Ferreira et al.,
2011). PIP is also reported to inhibit NO production in vivo
(Pradeep and Kuttan, 2003) and it also inhibited the growth of
Trypanosoma cruzi epimastigotes without NO induction (Freire-
de-Lima et al., 2008).
In vivo toxicity of the bioactive fractions was assessed at
higher dose (200 mg/ kg bw) in L. donovani infected mice.
In vitro toxicity of P. nigrum bioactive fractions had earlier
been studied against RAW macrophages where it was observed
that both PNH and PNE possessed high CC50 (50% inhibitory
concentration against macrophages) of 379.7 and 200 μg ml−1,
respectively, and were speciﬁc against L. donovani amastigotes
(Chouhan et al., 2014b). Hepatomegaly is one of the characteristic
clinical symptoms of VL and during the establishment of
infection, renal functions are also severely impaired (Prianti
et al., 2007). There was a signiﬁcant increase in enzymatic
activity of SGOT, SGPT, and ALP as well as urea and creatinine
concentration in INF and VC groups. Similar observations in
case of experimental VL have been demonstrated by others (Pal
et al., 2002; Kaur et al., 2013; Joshi et al., 2014). None of the
treatment groups signiﬁcantly altered serum levels of hepatic
and renal enzymes. Hepatoprotective potential of P. nigrum
(Nirwane and Bapat, 2012) and PIP (Sabina et al., 2010) has been
earlier reported and our ﬁndings also pointed toward inertness of
PNH and PNE toward hepatic and renal toxicity. The adversity
of antileishmanial chemotherapeutics and even of promising
drugs in experimental stage has always been the focal point
of criticism. Over the years, the search for potent as well as
equally safe or less toxic antileishmanial drugs has been elusive.
P. nigrum bioactive fractions in addition to being antileishmanial
and immunomodulatory, proved to be devoid of hepato- and
nephro-toxicity thereby suggesting that these fractions can be
a source of safe lead compounds with profound leishmanicidal
eﬃcacy.
In summary, drugs with immunomodulatory capacity have
evolved as promising therapeutic agents for the cure of infectious
diseases. In the present scenario, when conventional therapeutic
modalities against VL are of limited eﬃcacy with an escalating
threat of resistance, therapeutic switching to drugs which
can directly inhibit the growth of Leishmania parasites and
can liberate the host immune system of parasite induced
suppressive eﬀects, is urgently desired. Plants have been a
store house of biologically active substances endowed with
miscellaneous therapeutic properties and research over decades
has demonstrated that plants can yield diverse antileishmanial
molecules with immunomodulatory properties. Present study
clearly illustrated the promising leishmanicidal eﬃcacy of
P. nigrum bioactive fractions, which was substantiated by its
Th1 stimulatory potential with no signiﬁcant toxicity on host
liver and kidney. Thus, our ﬁndings point toward the candidacy
of P. nigrum as a source of potent and safe antileishmanial
compounds which after careful evaluation may beneﬁt VL
therapy as adjunct modality to complement the existing drugs.
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